"World's Most Complete Market Research Reports Repository"

Global Mental Disorders Drugs Market Size, Status and Forecast 2025

This report studies the global Mental Disorders Drugs market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Mental Disorders Drugs market by companies, region, type and end-use industry.

In 2017, the global Mental Disorders Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global top players, covered
Johnson and Johnson
Pfizer
Eli Lilly
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
...

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Market segment by Type, the product can be split into
Drugs for Schizophrenia
Antidepressants
Antipsychotics
Anxiolytics
Drugs for the Treatment of Substance and Alcohol Addiction
Drugs for Childhood and Adolescent Mental Illness
Drugs to Treat Cognitive Disorders
Sleep Disorders
Others

Market segment by Application, split into
Children
Adolescents
Adults

The study objectives of this report are:
To study and forecast the market size of Mental Disorders Drugs in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Mental Disorders Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Mental Disorders Drugs Manufacturers
Mental Disorders Drugs Distributors/Traders/Wholesalers
Mental Disorders Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Mental Disorders Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Mental Disorders Drugs Market Size, Status and Forecast 2025
1 Industry Overview of Mental Disorders Drugs
1.1 Mental Disorders Drugs Market Overview
1.1.1 Mental Disorders Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Mental Disorders Drugs Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Mental Disorders Drugs Market by Type
1.3.1 Drugs for Schizophrenia
1.3.2 Antidepressants
1.3.3 Antipsychotics
1.3.4 Anxiolytics
1.3.5 Drugs for the Treatment of Substance and Alcohol Addiction
1.3.6 Drugs for Childhood and Adolescent Mental Illness
1.3.7 Drugs to Treat Cognitive Disorders
1.3.8 Sleep Disorders
1.3.9 Others
1.4 Mental Disorders Drugs Market by End Users/Application
1.4.1 Children
1.4.2 Adolescents
1.4.3 Adults

2 Global Mental Disorders Drugs Competition Analysis by Players
2.1 Mental Disorders Drugs Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Johnson and Johnson
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Mental Disorders Drugs Revenue (Million USD) (2013-2018)
3.2 Pfizer
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Mental Disorders Drugs Revenue (Million USD) (2013-2018)
3.3 Eli Lilly
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Mental Disorders Drugs Revenue (Million USD) (2013-2018)
3.4 GlaxoSmithKline
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Mental Disorders Drugs Revenue (Million USD) (2013-2018)
3.5 AstraZeneca
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Mental Disorders Drugs Revenue (Million USD) (2013-2018)
3.6 Bristol-Myers Squibb
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Mental Disorders Drugs Revenue (Million USD) (2013-2018)

4 Global Mental Disorders Drugs Market Size by Type and Application (2013-2018)
4.1 Global Mental Disorders Drugs Market Size by Type (2013-2018)
4.2 Global Mental Disorders Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Mental Disorders Drugs in Future
4.4 Top Consumer/End Users of Mental Disorders Drugs

5 United States Mental Disorders Drugs Development Status and Outlook
5.1 United States Mental Disorders Drugs Market Size (2013-2018)
5.2 United States Mental Disorders Drugs Market Size and Market Share by Players (2013-2018)
5.3 United States Mental Disorders Drugs Market Size by Application (2013-2018)

6 Europe Mental Disorders Drugs Development Status and Outlook
6.1 Europe Mental Disorders Drugs Market Size (2013-2018)
6.2 Europe Mental Disorders Drugs Market Size and Market Share by Players (2013-2018)
6.3 Europe Mental Disorders Drugs Market Size by Application (2013-2018)

7 China Mental Disorders Drugs Development Status and Outlook
7.1 China Mental Disorders Drugs Market Size (2013-2018)
7.2 China Mental Disorders Drugs Market Size and Market Share by Players (2013-2018)
7.3 China Mental Disorders Drugs Market Size by Application (2013-2018)

8 Japan Mental Disorders Drugs Development Status and Outlook
8.1 Japan Mental Disorders Drugs Market Size (2013-2018)
8.2 Japan Mental Disorders Drugs Market Size and Market Share by Players (2013-2018)
8.3 Japan Mental Disorders Drugs Market Size by Application (2013-2018)

9 Southeast Asia Mental Disorders Drugs Development Status and Outlook
9.1 Southeast Asia Mental Disorders Drugs Market Size (2013-2018)
9.2 Southeast Asia Mental Disorders Drugs Market Size and Market Share by Players (2013-2018)
9.3 Southeast Asia Mental Disorders Drugs Market Size by Application (2013-2018)

10 India Mental Disorders Drugs Development Status and Outlook
10.1 India Mental Disorders Drugs Market Size (2013-2018)
10.2 India Mental Disorders Drugs Market Size and Market Share by Players (2013-2018)
10.3 India Mental Disorders Drugs Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Mental Disorders Drugs Market Size (Value) by Regions (2018-2025)
11.1.1 United States Mental Disorders Drugs Revenue and Growth Rate (2018-2025)
11.1.2 Europe Mental Disorders Drugs Revenue and Growth Rate (2018-2025)
11.1.3 China Mental Disorders Drugs Revenue and Growth Rate (2018-2025)
11.1.4 Japan Mental Disorders Drugs Revenue and Growth Rate (2018-2025)
11.1.5 Southeast Asia Mental Disorders Drugs Revenue and Growth Rate (2018-2025)
11.1.6 India Mental Disorders Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Mental Disorders Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Mental Disorders Drugs Market Size by Application (2018-2025)

12 Mental Disorders Drugs Market Dynamics
12.1 Mental Disorders Drugs Market Opportunities
12.2 Mental Disorders Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Mental Disorders Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Mental Disorders Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Global Mental Disorders Drugs Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Mental Disorders Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Mental Disorders Drugs Market Share by Regions (2013-2018)
Figure United States Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Europe Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Mental Disorders Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Mental Disorders Drugs Revenue Market Share by Type in 2017
Figure Drugs for Schizophrenia Market Size (Million USD) and Growth Rate (2013-2018)
Figure Antidepressants Market Size (Million USD) and Growth Rate (2013-2018)
Figure Antipsychotics Market Size (Million USD) and Growth Rate (2013-2018)
Figure Anxiolytics Market Size (Million USD) and Growth Rate (2013-2018)
Figure Drugs for the Treatment of Substance and Alcohol Addiction Market Size (Million USD) and Growth Rate (2013-2018)
Figure Drugs for Childhood and Adolescent Mental Illness Market Size (Million USD) and Growth Rate (2013-2018)
Figure Drugs to Treat Cognitive Disorders Market Size (Million USD) and Growth Rate (2013-2018)
Figure Sleep Disorders Market Size (Million USD) and Growth Rate (2013-2018)
Figure Others Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Mental Disorders Drugs Market Share by Application in 2017
Figure Mental Disorders Drugs Market Size (Million USD) and Growth Rate in Children (2013-2018)
Figure Mental Disorders Drugs Market Size (Million USD) and Growth Rate in Adolescents (2013-2018)
Figure Mental Disorders Drugs Market Size (Million USD) and Growth Rate in Adults (2013-2018)
Table Mental Disorders Drugs Market Size (Million USD) by Players (2013-2018)
Figure Mental Disorders Drugs Market Size Share by Players in 2013
Figure Mental Disorders Drugs Market Size Share by Players in 2017
Table Johnson and Johnson Basic Information List
Table Mental Disorders Drugs Business Revenue (Million USD) of Johnson and Johnson (2013-2018)
Figure Johnson and Johnson Mental Disorders Drugs Business Revenue Market Share (2013-2018)
Table Pfizer Basic Information List
Table Mental Disorders Drugs Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Mental Disorders Drugs Business Revenue Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Mental Disorders Drugs Business Revenue (Million USD) of Eli Lilly (2013-2018)
Figure Eli Lilly Mental Disorders Drugs Business Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table Mental Disorders Drugs Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
Figure GlaxoSmithKline Mental Disorders Drugs Business Revenue Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table Mental Disorders Drugs Business Revenue (Million USD) of AstraZeneca (2013-2018)
Figure AstraZeneca Mental Disorders Drugs Business Revenue Market Share (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Mental Disorders Drugs Business Revenue (Million USD) of Bristol-Myers Squibb (2013-2018)
Figure Bristol-Myers Squibb Mental Disorders Drugs Business Revenue Market Share (2013-2018)
Table Global Mental Disorders Drugs Market Size (Million USD) by Product (2013-2018)
Figure Global Mental Disorders Drugs Revenue Market Share (%) by Product (2013-2018)
Figure Global Mental Disorders Drugs Market Share by Product in 2017
Table Global Mental Disorders Drugs Market Size by Application (2013-2018)
Figure Global Mental Disorders Drugs Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Mental Disorders Drugs
Figure United States Mental Disorders Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Mental Disorders Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Mental Disorders Drugs Market Size Share by Players in 2013
Figure United States Mental Disorders Drugs Market Size Share by Players in 2017
Table United States Mental Disorders Drugs Market Size by Application (2013-2018)
Figure United States Mental Disorders Drugs Revenue Market Share (%) by Application (2013-2018)
Figure United States Mental Disorders Drugs Market Size Share by Application in 2017
Figure Europe Mental Disorders Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Europe Mental Disorders Drugs Market Size (Million USD) by Players (2013-2018)
Figure Europe Mental Disorders Drugs Market Size Share by Players in 2013
Figure Europe Mental Disorders Drugs Market Size Share by Players in 2017
Table Europe Mental Disorders Drugs Market Size by Application (2013-2018)
Figure Europe Mental Disorders Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Europe Mental Disorders Drugs Market Size Share by Application in 2017
Figure China Mental Disorders Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table China Mental Disorders Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Mental Disorders Drugs Market Size Share by Players in 2013
Figure China Mental Disorders Drugs Market Size Share by Players in 2017
Table China Mental Disorders Drugs Market Size by Application (2013-2018)
Figure China Mental Disorders Drugs Revenue Market Share (%) by Application (2013-2018)
Figure China Mental Disorders Drugs Market Size Share by Application in 2017
Figure Japan Mental Disorders Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Mental Disorders Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Mental Disorders Drugs Market Size Share by Players in 2013
Figure Japan Mental Disorders Drugs Market Size Share by Players in 2017
Table Japan Mental Disorders Drugs Market Size by Application (2013-2018)
Figure Japan Mental Disorders Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Japan Mental Disorders Drugs Market Size Share by Application in 2017
Figure Southeast Asia Mental Disorders Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Mental Disorders Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Mental Disorders Drugs Market Size Share by Players in 2013
Figure Southeast Asia Mental Disorders Drugs Market Size Share by Players in 2017
Table Southeast Asia Mental Disorders Drugs Market Size by Application (2013-2018)
Figure Southeast Asia Mental Disorders Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Mental Disorders Drugs Market Size Share by Application in 2017
Figure India Mental Disorders Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table India Mental Disorders Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Mental Disorders Drugs Market Size Share by Players in 2013
Figure India Mental Disorders Drugs Market Size Share by Players in 2017
Table India Mental Disorders Drugs Market Size by Application (2013-2018)
Figure India Mental Disorders Drugs Revenue Market Share (%) by Application (2013-2018)
Figure India Mental Disorders Drugs Market Size Share by Application in 2017
Figure Global Mental Disorders Drugs Market Size and Growth Rate (2018-2025)
Table Global Mental Disorders Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Mental Disorders Drugs Market Size Share (2018-2025)
Figure Global Mental Disorders Drugs Market Size Share by Regions in 2025
Figure United States Mental Disorders Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Europe Mental Disorders Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Mental Disorders Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Mental Disorders Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Mental Disorders Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Mental Disorders Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Mental Disorders Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Mental Disorders Drugs Market Size Share by Type in 2018
Figure Global Mental Disorders Drugs Market Size Share by Type in 2025
Table Global Mental Disorders Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Mental Disorders Drugs Market Size (Million USD) by Application in 2018

Choose License Type